The Saudi Arabia Capital Markets Authority has approved Dallah Healthcare Co.’s request to increase its capital to acquire 97.41% of Al-Ahsa Medical Services Co. and all shares of Al-Salam Medical Services Co., both owned by Ayyan Investment Co. The transaction will be executed through a capital increase from SAR 976,811,660 to SAR 1,015,747,690 via the issuance of 3,893,603 ordinary shares. A shareholder circular will be published sufficiently ahead of the Extraordinary General Assembly meeting and must include relevant information for shareholders, including details of the capital increase and risk factors. The CMA noted that its approval reflects satisfaction of legal requirements under the Capital Market Law and its implementing regulations and should not be treated as an endorsement of the feasibility of the proposed capital increase for the stated purpose.
Saudi Arabia Capital Markets Authority 2025-02-05
Saudi Arabia Capital Markets Authority approves Dallah Healthcare capital increase to fund acquisition of Al-Ahsa Medical Services and Al-Salam Medical Services stakes
The Saudi Arabia Capital Markets Authority approved Dallah Healthcare Co.'s capital increase to acquire 97.41% of Al-Ahsa Medical Services Co. and all shares of Al-Salam Medical Services Co. from Ayyan Investment Co. The capital will rise from SAR 976,811,660 to SAR 1,015,747,690 through issuing 3,893,603 ordinary shares. The CMA emphasized that its approval confirms legal compliance but does not endorse the feasibility of the capital increase.